DENTERIC
Denteric is developing a vaccine based on research conducted at the University of Melbourne, with collaborative support from CSL Limited, to fight the disease and will receive the money in three parts each year from 2019 to 2021.
DENTERIC
Industry:
Health Care
Founded:
2019-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.denteric.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
14 M AUD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Google GStatic Google Static Content
Current Employees Featured
Founder
Investors List
Medical Research Commercialisation Fund (MRCF)
Medical Research Commercialisation Fund (MRCF) investment in Series A - Denteric
Brandon Capital Partners
Brandon Capital Partners investment in Series A - Denteric
CSL
CSL investment in Series A - Denteric
United News of India
United News of India investment in Series A - Denteric
Official Site Inspections
http://www.denteric.com
- Host name: 170.64.250.197
- IP address: 170.64.250.197
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Denteric"
DentRec: Advanced Financial Reconciliation Software for Dental …
Protect your dental practice from financial discrepancies with DentRec's user-friendly software. Achieve seamless integration with your PMS, bank, and financial systems for accurate, real … See details»
About us - denteric.com
Prior to joining Denteric, Michal was a postdoctoral scientist at WEHI and while in this role, he completed an internship at the WEHI’s Business Development Office and the Bridge Program. … See details»
denteric.com Reviews | check if site is scam or legit| Scamadviser
Check denteric.com with our free review tool and find out if denteric.com is legit and reliable. Need advice? Report scams Check Scamadviser! See details»
Denteric: Precision immunotherapies for chronic _Porphyromonas ...
Denteric is developing therapies for Porphyromonas gingivalis (Pg) related diseases – initially focused on severe periodontal disease. Our first product is a therapy designed to neutralise … See details»
Denteric - Crunchbase Company Profile & Funding
Denteric is developing a vaccine based on research conducted at the University of Melbourne, with collaborative support from CSL Limited, to fight the disease and will receive the money in … See details»
Denteric enters Phase I clinical trials
Denteric is pleased to announce that its first subjects have been dosed today in its first in human safety study of GPV381, a therapy designed to treat severe periodontal disease. The phase 1 … See details»
Denteric therapies
About Denteric We are a clinical-stage biotech company developing therapies with the potential to treat diseases associated with Porphyromonas gingivalis (Pg), such as periodontal disease. … See details»
Michal Pasternak - Research Project Manager at Denteric | The Org
He manages Denteric’s mRNA vaccine and Alzheimer’s disease research programs. Prior to joining Denteric, Michal was a postdoctoral scientist at WEHI. In addition to this role, he … See details»
Top Denteric Competitors and Alternatives | Craft.co
Denteric's main competitors include Oragenics, PreBiomics, Vitaldent and Mimetis Biomaterials. Compare Denteric to its competitors by revenue, employee growth and other metrics at Craft. See details»
Denteric 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Denteric. Use the PitchBook Platform to explore the full profile. See details»
Denteric | VentureRadar
DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and production in Denmark and … See details»
Larisa Chisholm - COO at Denteric | The Org
Larisa is an experienced life science executive with a passion for the development and commercialisation of Australian technologies. See details»
Director, Product Development at Denteric - The Org
Prior to joining Denteric, Gerhard was employed at Boehringer Ingelheim (BI) in Germany where he led CMC teams in the company’s CDMO business before becoming R&D Project Leader … See details»
Denteric - Contacts, Employees, Board Members, Advisors & Alumni
Denteric is developing a vaccine based on research conducted at the University of Melbourne. See details»
Denteric Company Profile - Office Locations, Competitors ... - Craft
Denteric has 1 employees at their 1 location and $9.46 m in total funding,. See insights on Denteric including office locations, competitors, revenue, financials, executives, subsidiaries … See details»
Larisa Chisholm - Chief Operating Officer @ Denteric - Crunchbase
Overview CB Rank (Person) 1,131,242 Primary Job Title Chief Operating Officer Primary Organization Denteric Location Melbourne, Victoria, Australia Regions Asia-Pacific (APAC), … See details»
Chris Smith - Director at Denteric | The Org
Chris is a Senior Investment Manager with Brandon Capital Partners, Australia’s largest life-science VC, and manager of the Medical Research Commercialisat See details»
Denteric - Brandon Capital
Denteric is developing vaccines that target the major virulence factors produced by the bacterium Porphyromonas gingivalis (P gingivalis) and related species. In so doing, its primary goal is to … See details»
Denteric - Products, Competitors, Financials, Employees, …
Denteric's vaccine therapy is intended to generate antibodies against the proteolytic toxins of the bacteria linked to periodontal disease and inflammation, and it is currently undergoing phase I … See details»
Denteric - Headquarter Location, Corporate Office Address and …
Find business data of Denteric. Know the headquarter data such: location, corporate office address and opening hours of Denteric. See details»